Ebru Selen1, Kevin P Bateman2, Ismael Zamora3, Rahul Baghla1and Eshani Galermo1
1SCIEX, USA, 2KDAM Consulting, Canada and 3Mass Analytica, Spain
This technical note introduces an innovative software solution designed to simplify the complexities of high-resolution mass spectra, delivering quick and accurate quantitative results (Figure 1). High-resolution mass spectrometers (HRMSs) are gaining momentum in the drug discovery process for quantitative analysis due to their flexibility in choosing various workflows, including MS1, MRMHR, and SWATH DIA and streamlined method development compared to conventional triple quadrupole mass spectrometers.
The challenge with HRMS for quantitative analysis is optimizing data processing, as manually analyzing complex mass spectra is time-consuming. Users need to evaluate mass spectra to identify intense fragments, align them with structures and optimize extraction windows for quantitation. Here, AI Quantitation software was applied to automatically select optimal MS and MS/MS signals based on compound structure and peak quality parameters (i.e. S/N, extraction window), demonstrating the best method to meet user-defined quantitative criteria (precision, accuracy and dynamic range).1
Figure 1. Workflow using AI Quantitation software on SCIEX MS platforms. The figure shows the workflow for the quantitation experiment to analyze biological PK samples using SCIEX mass spectrometers and data processing using AI Quantitation software with the final result layout.
MRM on nominal mass spectrometers is the most common methodology for quantitation experiments. MRMHR on HRMS takes it to the next level as one of the most selective methodologies for supporting high-throughput pharmacokinetic (PK) studies in drug discovery. MRMHR is a targeted analysis technique focusing exclusively on selected precursor ions for MS/MS-based quantitation experiments, helping ensure high selectivity and sensitivity.
SWATH DIA is another powerful methodology that is rapidly gaining momentum in drug discovery. Unlike MRMHR, SWATH DIA provides comprehensive MS/MS information for all precursor ions. This approach is particularly valuable for metabolite identification, characterization studies and quantitation using more selective MS/MS spectra.
Quantitation using SWATH DIA MS/MS spectra traditionally requires extensive manual optimization due to their complexity, posing a significant barrier to their use in quantitation experiments. However, AI Quantitation software helps eliminate this barrier by employing innovative algorithms to simplify data processing, making it the preferable methodology for all drug discovery needs.1
Samples: Mass Analytica provided ready-to-inject rat in-vivo sitagliptin PK study samples for evaluation. The samples included IV and oral PK study samples, standard calibration curve, quality control and blank samples.
Chromatography: Analytical separation was performed on the ExionLC AE system using an Acquity BEH C18 column (2.1 x 50 mm, 1.7 µm) at a 0.4 mL/min flow rate. Mobile phase A was 0.1% (v/v) formic acid in water and mobile phase B was 0.1% (v/v) formic acid in acetonitrile. The column temperature was set to 40°C. The gradient conditions used are summarized in Table 1. A 2 μL sample was used for LC-MS/MS analysis.
Mass spectrometry: Samples were analyzed using MRMHR, SWATH DIA and MRM experiments using SCIEX HRMS and nominal mass spectrometers. Optimized source and gas parameters along with MRMHR and SWATH DIA parameters are included in Table 2. For the MRM experiment using a nominal mass spectrometer, m/z 408.1/235.1 was used as Q1/Q3.
Data processing: Data acquisition was performed using SCIEX OS software, version 3.4.5. Data processing was performed using AI Quantitation software.
Table 1. LC gradient conditions.
Table 2. Source, gas and mass spectrometer system conditions.
MRM, MRMHR and SWATH DIA acquisition data files were processed using AI Quantitation software using the same processing methods and parameters for evaluation. The acquisition batch was composed of 3 replicates of the calibration curve interspersed in the beginning, middle and end of the batch, along with quality control and unknown PK samples.
All samples were processed using AI Quantitation software. The processing method includes a bond-breaking algorithm which automatically assigns fragment ions (if present) per compound of interest. All signals related to the molecule are then used to select a subset of ions that provide the best overall performance for the quantitative assay. The algorithm calculates peak areas using all possible combinations of the ions selected using the limits set within the software. Furthermore, it helps ensure high precision and accuracy by dynamically optimizing these parameters. This approach enhances reproducibility and consistency, making it highly reliable for advanced analytical workflows.
The software automatically predicted and applied the summing of [M+H]+, [M+1+H]+ and fragment ion m/z 193.0696 for the peak identification based on user-defined criteria (Figure 2) to achieve the best lower limit of quantitation (LLOQ) for the experiment (Figure 3).
Figure 2. User-defined criteria for peak quality, replicate parameters and concentration parameters.
Figure 3. Peak preview from AI Quantitation software. 1 ng/mL (top, LLOQ) and 2 ng/mL (bottom) peaks from AI Quantitation software showing the sum of ions and individual ion peaks.
Analytical performance was evaluated based on the accuracy and precision metric of ±25% for standards and quality control samples used in the discovery stage quantitative assays.1 Calculated %accuracy and %CV values were within the acceptance criteria at each concentration level for all experiments (Table 3).
LLOQ, upper limit of quantitation (ULOQ) and linear dynamic range (LDR) focused processing were performed. Good linearity was achieved using all 3 MRMHR, SWATH DIA and MRM experiments with an LLOQ of 1 ng/mL and ULOQ of 5000 ng/mL. ULOQ for nominal mass experiment was 2000 ng/mL. All experiments achieved an LDR of >3 orders of magnitude with a weighting factor of 1/x2 (Figure 4).
Figure 4. Representative calibration curve for sitagliptin from SWATH DIA experiment using AI Quantitation software.
Table 3. Quantitative performance of sitagliptin. Reproducibility and accuracy results from the AI Quantitation software for standards and quality control samples using MRMHR, SWATH DIA and MRM experiments.
Unknown rat PK samples (IV and oral studies) were back-calculated automatically using the calibration curves from each experiment. PK profiles were plotted to show the data reproducibility with both data acquisition experiments MRMHR and SWATH DIA (Figure 5).
Figure 5. Pharmacokinetic log plasma concentration (Cp) profiles from unknown rat IV samples (left) and unknown rat oral samples (right) demonstrating data equivalency between all 3 different experiments (MRMHR, SWATH DIA and MRM).